JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FISHBEIN, W. N.
Right arrow Articles by STREETER, C. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FISHBEIN, W. N.
Right arrow Articles by STREETER, C. L.
Journal of Pharmacology And Experimental Therapeutics, Vol. 174, Issue 2, 239-246, 1970
Copyright © 1970 by American Society for Pharmacology and Experimental Therapeutics


PHYSIOLOGIC DISPOSITION OF SHORT CHAIN ALIPHATIC HYDROXAMATES IN THE MOUSE. I. THE ONE-THROUGH-FOUR CARBON HYDROXAMATES: EXCRETION AND CONVERSION TO AMIDES

WILLIAM N. FISHBEIN 1 and CHARLES L. STREETER 1

1 Biochemistry Branch, Armed Forces Institute of Pathology, Washington, D.C.

The excretion and metabolism of four homologous hydroxamic acids in mice has been studied, with acetohydroxamate as the index compound. Urinary excretion of these compounds was very rapid, yet incomplete. In the case of acetohydroxamate more than 90% of the total amount excreted was present in the first 8-hour urine collection, yet only 65 to 70% of the administered dose was recovered in 48-hour urine specimens. The urinary percent recovery of acetohydroxamate was constant over a 5-fold dose range (160-800 mg/kg b.w.), and was also unaffected by pretreatment of the animals with barbital or 3-methylcholanthrene. Urinary recovery of the congeneric compounds was much lower: 24% for formohydroxamate, 34% for propionohydroxamate and 35% for isobutyrohydroxamate. Evidence for the appearance in the urine of the corresponding amide to each of the administered hydroxamates was obtained by paper or thin-layer chromatography. In the case of acetohydroxamate, urinary acetamide accounted for 10 to 20% of the administered dose and was therefore a major metabolite. In the case of the other compounds, however, the amide recovery was much lower, and more than half the administered dose remained unaccounted for in this study. The use of isotopically labeled hydroxamates would appear to be essential in the further study of the physiologic disposition of these compounds.

Submitted on September 9, 1969
Accepted on April 19, 1970







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1970 by the American Society for Pharmacology and Experimental Therapeutics.